CBD American Shaman, LLC

Warning LetterOpen

United StatesIssued Nov 16, 2022Center for Food Safety and Applied Nutrition (CFSAN)

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations0

Issue DateNov 16, 2022

Product TypeAnimal & Veterinary

StatusOpen

Letter Details

Firm: CBD American Shaman, LLC
Location: United States
FEI Number: N/A
Country: United States
Issue Date: November 16, 2022
Issuing Office: Center for Food Safety and Applied Nutrition (CFSAN)
Product Type: Animal & Veterinary
Status: Open

Summary

Based on limited metadata, the FDA issued a Warning Letter to CBD American Shaman, LLC on November 16, 2022, regarding animal and veterinary products containing cannabidiol (CBD). While the specific violations are not detailed in the available metadata, the letter indicates regulatory concerns about how the company marketed or formulated CBD-containing animal or veterinary products. The warning falls under FDA's oversight of animal and veterinary product compliance, though the issuing office details are not available in this summary.

CBD American Shaman, LLC FDA Warning Letter, November 16, 2022